CNPAX
Price
$71.09
Change
-$0.07 (-0.10%)
Updated
Nov 19 closing price
Net Assets
158.87B
NFACX
Price
$35.87
Change
-$0.12 (-0.33%)
Updated
Nov 19 closing price
Net Assets
807.38M
Interact to see
Advertisement

CNPAX vs NFACX

Header iconCNPAX vs NFACX Comparison
Open Charts CNPAX vs NFACXBanner chart's image
American Funds New Perspective 529A
Price$71.09
Change-$0.07 (-0.10%)
VolumeN/A
Net Assets158.87B
Neuberger Berman Focus C
Price$35.87
Change-$0.12 (-0.33%)
VolumeN/A
Net Assets807.38M
CNPAX vs NFACX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. NFACX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and NFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 159B vs. NFACX (807M). CNPAX pays higher dividends than NFACX: CNPAX (0.45) vs NFACX (0.00). CNPAX was incepted earlier than NFACX: CNPAX (24 years) vs NFACX (15 years). NFACX (1.96) is less costly to investors than CNPAX (0.77). NFACX is a more actively managed with annual turnover of: 38.00 vs. CNPAX (24.00). CNPAX has a lower initial minimum investment than NFACX: CNPAX (250) vs NFACX (1000). NFACX annual gain was more profitable for investors over the last year : 16.70 vs. CNPAX (11.66). CNPAX return over 5 years is better than : 27.82 vs. NFACX (15.18).
CNPAXNFACXCNPAX / NFACX
Total Expense Ratio0.771.8741%
Annual Report Gross Expense Ratio0.771.9639%
Fund Existence24 years15 years-
Gain YTD16.48417.75693%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets159B807M19,703%
Annual Yield % from dividends0.450.00-
Returns for 1 year11.6616.7070%
Returns for 3 years47.0970.5667%
Returns for 5 years27.8215.18183%
Returns for 10 years95.85-38.08-252%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SF118.621.82
+1.56%
Stifel Financial Corp
CSTM14.890.14
+0.95%
Constellium SE
AKBA1.59-0.06
-3.64%
Akebia Therapeutics
XBP0.62-0.04
-6.75%
XBP Global Holdings Inc
LRHC2.15-0.45
-17.31%
La Rosa Holdings Corp